[Importance of Quick, partial thromboplastin time, and Co]

Area of Science:

• Coagulation and Hemostasis
• Clinical Pathology
• Diagnostic Assays

Context:

• The Quick test and activated partial thromboplastin time (aPTT) are widely used global assays for evaluating plasmatic hemostasis.
• These tests reflect the extrinsic and intrinsic pathways but do not encompass cell-based hemostasis.
• Clinical interpretation requires consideration of patient history, as results may not align with specific bleeding or thrombotic risks.

Purpose:

• To elucidate the diagnostic utility and limitations of the Quick test and aPTT in characterizing hemostatic disorders.
• To highlight specific clinical conditions where these global assays may yield normal or misleading results.
• To emphasize the necessity of integrating global assay results with clinical presentation and other diagnostic tools.

Summary:

• The Quick test and aPTT assess different aspects of coagulation but have limitations in reflecting cell-based hemostasis and certain clinical conditions like hemophilia A/B or factor XII deficiency.
• Pathological results in these tests can indicate fibrinogen reduction, liver synthesis disorders, or vitamin K deficiency.
• Prolonged aPTT is common in hemophilia A/B and von Willebrand disease, while acquired bleeding tendencies may involve autoantibodies. Reagent sensitivity impacts results with certain inhibitors.

Impact:

• Provides a nuanced understanding of the diagnostic capabilities and shortcomings of standard hemostasis assays.
• Guides clinicians in interpreting Quick test and aPTT results within the broader clinical context.
• Underscores the importance of a comprehensive diagnostic approach for hemostatic disorders, beyond global assays alone.